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ABSTRACT Gastrointestinaldisturbancesarecommonlyreportedinchildrenwithautismandmaybeassociatedwithcomposi-
tionalchangesinintestinalbacteria.Inapreviousreport,wesurveyedintestinalmicrobiotainilealandcecalbiopsysamples
fromchildrenwithautismandgastrointestinaldysfunction(AUT-GI)andchildrenwithonlygastrointestinaldysfunction
(Control-GI).Ourresultsdemonstratedthepresenceofmembersofthefamily AlcaligenaceaeinsomeAUT-GIchildren,while
noControl-GIchildrenhad Alcaligenaceaesequences.Herewedemonstratethatincreasedlevelsof Alcaligenaceaeinintestinal
biopsysamplesfromAUT-GIchildrenresultfromthepresenceofhighlevelsofmembersofthegenus Sutterella.Wealsoreport
theﬁrstSutterella-speciﬁcPCRassaysfordetecting,quantitating,andgenotyping Sutterellaspeciesinbiologicalandenviron-
mentalsamples.Sutterella16SrRNAgenesequenceswerefoundin12of23AUT-GIchildrenbutinnoneof9Control-GIchil-
dren. Phylogenetic analysis revealed a predominance of either Sutterella wadsworthensis or Sutterella stercoricanis in 11 of the
individualSutterella-positiveAUT-GIpatients;inoneAUT-GIpatient, Sutterellasequenceswereobtainedthatcouldnotbe
givenaspecies-levelclassiﬁcationbasedonthe16SrRNAgenesequencesofknown Sutterellaisolates.Westernimmunoblots
revealed plasma IgG or IgM antibody reactivity to Sutterella wadsworthensis antigens in 11 AUT-GI patients, 8 of whom were
alsoPCRpositive,indicatingthepresenceofanimmuneresponseto Sutterellainsomechildren.
IMPORTANCE Autismspectrumdisordersaffect~1%ofthepopulation.Manychildrenwithautismhavegastrointestinal(GI)
disturbancesthatcancomplicateclinicalmanagementandcontributetobehavioralproblems.Understandingthemolecularand
microbialunderpinningsoftheseGIissuesisofparamountimportanceforelucidatingpathogenesis,renderingdiagnosis,and
administeringinformedtreatment.Herewedescribeanassociationbetweenhighlevelsofintestinal,mucoepithelial-associated
SutterellaspeciesandGIdisturbancesinchildrenwithautism.Theseﬁndingselevatethislittle-recognizedbacteriumtothe
forefrontbydemonstratingthat Sutterellaisamajorcomponentofthemicrobiotainoverhalfofchildrenwithautismandgas-
trointestinaldysfunction(AUT-GI)andisabsentinchildrenwithonlygastrointestinaldysfunction(Control-GI)evaluatedin
thisstudy.Furthermore,theseﬁndingsbringintoquestiontherole Sutterellaplaysinthehumanmicrobiotainhealthanddis-
ease.WiththeSutterella-speciﬁcmolecularassaysdescribedhere,someofthesequestionscanbegintobeaddressed.
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A
utismspectrumdisorders(ASD)arepervasivedevelopmental
disordersthatdependontriadicpresentationofsocialabnor-
malities, communication impairments, and stereotyped and re-
petitive behaviors for diagnosis (DSM-IV-TR criteria, American
Psychiatric Association, 2000). Gastrointestinal (GI) symptoms
arecommonlyreportedinchildrenwithautismandmaycorrelate
with autism severity (1, 2). Intestinal disturbances in autism have
been associated with macroscopic and histological abnormalities,
altered inﬂammatory parameters, and various functional distur-
bances (3–9).
In a previous study, we showed that a complex interplay exists
betweenhumanintestinalgeneexpressionfordisaccharidasesand
hexose transporters and compositional differences in the mu-
coepithelial microbiota of children with autism and gastrointesti-
nal disease (AUT-GI children) compared to children with GI dis-
ease but typical neurological status (Control-GI children).
Signiﬁcant compositional changes in Bacteroidetes, Firmicutes/
Bacteroidetes ratios, and Betaproteobacteria in AUT-GI intestinal
biopsy samples have been reported (10). Although others have
demonstratedchangesinfecalbacteriaofchildrenwithautism(2,
11–15), our study differed from these by investigating mucoepi-
thelial microbiota (10). The GI microbiota plays an essential role
in physiological homeostasis in the intestine and periphery, in-
cludingmaintainingresistancetoinfection,stimulatingimmuno-
logicaldevelopment,andperhapseveninﬂuencingbraindevelop-
ment and behavior (16–19). Thus, disruption of the balanced
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could have profound effects on human health.
In our previous metagenomic study, we found sequences cor-
responding to members of the family Alcaligenaceae in the class
Betaproteobacteriathatwerepresentinilealandcecalbiopsysam-
ples from 46.7% (7/15) of AUT-GI children. Alcaligenaceae se-
quences were completely absent from biopsy samples from
Control-GI children (10). Members of the family Alcaligenaceae
inhabitdiversehabitats,rangingfromhumansandanimalstosoil
(20). Several members of Alcaligenaceae cause clinically relevant
infections or are suspected opportunistic pathogens in humans
and animals, including members of the genus Bordetella (includ-
ing the human respiratory pathogens B. pertussis and B. paraper-
tussis,themammalianrespiratorypathogenB.bronchiseptica,and
the poultry respiratory pathogen B. avium), a member of the ge-
nus Alcaligenes (the human opportunistic pathogen A. faecalis),
members of the genus Achromobacter (the human opportunistic
pathogens A. xylosoxidans and A. piechaudii), members of the ge-
nus Oligella (the potential opportunistic genitourinary species O.
urethralisandO.ureolytica),amemberofthegenusTaylorella(the
equineurogenitalpathogen,T.equigenitalis),andamemberofthe
genus Pelistega (the pigeon respiratory pathogen P. europaea)
(20).
Insomecases,thepathogenicpotentialofAlcaligenaceaemem-
bers is unclear. The genus Sutterella represents one such member.
MembersofthegenusSutterellaareanaerobicormicroaerophilic,
bile-resistant, asaccharolytic, Gram-negative, short rods (21).
Members of the genus Sutterella have been isolated from human
infectionsbelowthediaphragm(22,23).Sutterella16SrRNAgene
sequences have also been identiﬁed in intestinal biopsy and fecal
samplesfromindividualswithCrohn’sdiseaseandulcerativecoli-
tis (24, 25). Whether the presence of Sutterella species at sites of
human infection and inﬂammation represents cause or conse-
quence or whether Sutterella is a normal part of the microbiota in
some individuals remains unclear. The dearth of knowledge con-
FIG1 PresenceofSutterellasequencesinasubsetofAUT-GIpatients.Shown
are the results from detection by pyrosequencing of the V2 region of the 16S
rRNA gene. (A and B) Distribution of Sutterella sequences as a percentage of
total bacterial 16S rRNA gene reads from ileal (A; Mann-Whitney, tied P 
0.022) and cecal (B; Mann-Whitney, tied P  0.037) biopsy samples from
AUT-GIandControl-GIpatients.(CtoF)DistributionofSutterellasequences
by individual patient as a percentage of total bacteria (C and D) or total Beta-
proteobacteria(EandF)16SrRNAreadsfromileal(CandE)andcecal(Dand
F)biopsysamplesfromAUT-GI(patients1to15)andControl-GI(patients16
to 22) patients. *, P  0.05.
FIG 2 Pie chart indicating the percentage of Sutterella sequences in the
dominantOTU(eitherOTU1orOTU2)relativetosequencesfromsubdomi-
nant Sutterella OTUs in ileum and cecum of the seven Sutterella-positive pa-
tients. The percentage of the dominant OTU is shown per patient.
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derives in part from the lack of speciﬁc, culture-independent as-
says to detect and characterize members of this genus.
Here we further characterize Alcaligenaceae sequences identi-
ﬁed in AUT-GI children and describe PCR assays for detection,
quantitation, and genotyping of Sutterella as well as serological
assays for detection of immunological responses to Sutterella.
RESULTS
High levels of Sutterella in a subset of AUT-GI patients identi-
ﬁed by pyrosequencing. Our previous pyrosequencing results
(10)demonstratedahighabundanceofsequencesfromthefamily
AlcaligenaceaeinnearlyhalfofAUT-GIchildren(patients1to15)
and the absence of corresponding sequences in Control-GI chil-
dren (patients 16 to 22) and prompted a more detailed investiga-
tionofthesetaxaofbacteria.Genus-levelanalysisofpyrosequenc-
ing reads revealed that all sequences of Alcaligenaceae found in
AUT-GI patients’ biopsy samples were classiﬁed as members of
thegenusSutterella.Theaverageconﬁdenceestimateofallgenus-
level Ribosomal Database Project (RDP)-classiﬁed Sutterella se-
quences was high (99.1%), with the majority of sequences classi-
ﬁed at 100% conﬁdence.
Comparison of Sutterella abundance from pyrosequencing
reads revealed signiﬁcant increases in Sutterella in the ilea
(Fig.1A)(Mann-Whitney,tiedPvalue0.022)andceca(Fig.1B)
(Mann-Whitney, tied P value  0.037) of AUT-GI children com-
pared to Control-GI children. Individual analysis of AUT-GI pa-
tients revealed that 46.7% (7/15) of AUT-GI patients (patients 1,
3, 5, 7, 10, 11, and 12) had high levels of Sutterella 16S rRNA gene
sequences in both the ileum (Fig. 1C; see Table S1 in the supple-
mental material) and cecum (Fig. 1D; see Table S1). Sutterella
sequenceswereabsentfromallControl-GIsamples(patients16to
22). In those seven AUT-GI patients with Sutterella sequences,
FIG 3 Sutterella-speciﬁc PCR assays. (A) Schematic representation showing
the location of PCR primers and products evaluated in this study. (B)
Sutterella-speciﬁc 16S rRNA gene (V6–V8) PCR ampliﬁcation of 10-fold di-
lutions of Sutterella plasmid DNA standards spiked into ileal DNA from a
Sutterella-negative Control-GI patient. Note the linear ampliﬁcation down to
5  102 copies and the endpoint detection limit of 5  101 copies. (C) Real-
time PCR ampliﬁcation plot of 10-fold serial dilutions of Sutterella plasmid
DNA standards. Rn, magnitude of the signal generated by the PCR condi-
tions. (D) Standard curve generated from our Sutterella-speciﬁc quantitative
real-time PCR assay.
FIG 4 PCR-based detection of Sutterella 16S rRNA gene sequences (V6–V8
regionandC4–V8region)inbiopsiesfromAUT-GIandControl-GIpatients.
(A) Agarose gel detection of 260-bp Sutterella products in ileal (4 biopsy sam-
ples/patient) and cecal (4 biopsy samples/patient) biopsy DNA using SuttFor
andSuttRevprimers(V6–V8region)inconventionalPCRassays.(B)Agarose
geldetectionof715-bpSutterellaproductsinilealandcecalbiopsyDNAusing
pan-bacterial primer 515For and SuttRev primer (C4–V8) in conventional
PCR assays. The negative control is PCR reagents with water substituted for
DNA. The positive control is DNA isolated from cultured S. wadsworthensis
(ATCC 51579).
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total bacterial reads (Fig. 1C; see Table S1). For the same patients,
cecal Sutterella sequence abundance ranged from 2.0 to 7.0% of
total bacterial reads (Fig. 1D; see Table S1).
ToputthelevelsofSutterellainthesepatientsintoperspective,
we ranked the abundance of all ileal and cecal genus-level classiﬁ-
cations from our pyrosequencing results. In the ileum, Sutterella
sequencesrepresentedthefourthmostabundantgenusforpatient
1, the sixth most abundant genus for patient 3, the ﬁfth most
abundant genus for patient 5, the ﬁfth most abundant genus for
patient7,thethirdmostabundantgenusforpatient10,theeighth
most abundant genus for patient 11, and the ﬁfth most abundant
genus for patient 12 (see Fig. S1 and S2 in the supplemental ma-
terial). Similar rankings were obtained in the cecum of these pa-
tients (data not shown).
Sutterella sequences represented the majority of sequences
present in the class Betaproteobacteria in these seven AUT-GI pa-
tients. In ileal biopsy samples from the seven AUT-GI patients
with Sutterella sequences, Sutterella sequences accounted for
75.6% to 97.8% of all Betaproteobacteria sequences (Fig. 1E; see
Table S1 in the supplemental material). In cecal biopsy samples,
Sutterella sequences accounted for 92.1% to 98.2% of all Betapro-
teobacteria sequences (Fig. 1F; see Table S1).
OTU and sequence analysis of Sutterella sequences in
AUT-GIchildren.Operationaltaxonomicunit(OTU)analysisof
V2pyrosequencingreadsinileum(seeFig.S3Ainthesupplemen-
tal material) and cecum (see Fig. S3B) revealed that sequences
from patients 1, 3, 10, 11, and 12 clustered together with OTU 2
containing the majority of Sutterella sequences, and sequences
from patients 5 and 7 clustered together with OTU 1 containing
the majority of Sutterella sequences. OTU 2 accounted for 87%
and 84% for patient 1, 85% and 87% for patient 3, 66% and 66%
forpatient10,87%and85%forpatient11,and81%and81%for
patient 12 of all Sutterella sequences obtained by pyrosequencing
of the 16S rRNA gene in ileum and cecum, respectively (Fig. 2).
OTU1accountedfor88%and86%forpa-
tient5and88%and83%forpatient7ofall
Sutterella sequences obtained by pyrose-
quencing of the V2 region of the 16S rRNA
gene in ileum and cecum, respectively
(Fig.2).SubdominantOTUsmayrepresent
true phylotypes, but they could also arise
from PCR or sequencing artifacts. We fo-
cused our analysis on those OTUs contain-
ing the majority of Sutterella sequences,
namely, OTU 1 and OTU 2.
The representative sequences from
OTU 1 and OTU 2 were aligned and used
for phylogenetic analysis (see Fig. S4 in the
supplemental material). The representative
sequencefromOTU1wasphylogenetically
most closely related to the species S. wad-
sworthensis; the representative sequence
from OTU 2 was most closely related to S.
stercoricanis. Although some branches in
the tree are clearly differentiated by high
bootstrap values, others are differentiated
poorly by low bootstrap values. Further-
more, members of the genera Comamonas
and Burkholderia were grouped with mem-
bersofthegenusSutterella.ThissuggeststhatsequencesfromtheV2
region alone may be insufﬁcient for accurate species-level phyloge-
netic analysis of Sutterella sequences.
ConﬁrmationandquantitationofSutterellasequencesusing
novel PCR assays. To independently verify V2 pyrosequencing
results for Sutterella, we designed Sutterella-speciﬁc PCR assays
FIG 5 Quantitation of Sutterella sequences in ileal and cecal biopsy samples from AUT-GI and
Control-GIpatientsusinganovelSutterella-speciﬁcreal-timePCRassay.Barsinthegraphshowmean
copy number in 4 biopsy samples from ileum (blue) and 4 biopsy samples from cecum (red)  the
standard error of the mean (SEM) for each patient.
FIG6 DistributionofSutterellaspeciesinilealandcecalbiopsysamplesfrom
AUT-GI patients based on C4–V8 products. The closest sequence match to
known Sutterella isolates was determined using the RDP seqmatch tool. The
frequency of Sutterella species matches in ileal and cecal clone libraries are
shownaspiechartsforpatients1(A),3(B),5(C),7(D),10(E),11(F),12(G),
24a (H), 25a (I), 27a (J), 28a (K), and 29a (L). *, Sutterella 16S sequences
obtainedfrompatient28awerelessthan97%similartothe16Ssequenceofall
known isolates of Sutterella species.
Williams et al.
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primers that amplify a 260-bp region spanning the regions from
V6 to V8 (V6–V8 PCR) of the 16S rRNA gene (SuttFor and Sutt-
Rev primers) (Fig. 3A to 3D). Conventional PCR analysis using
DNA from each of 4 ileal and 4 cecal biopsy samples per patient
showed that the same individuals identiﬁed as having high levels
of Sutterella by V2 pyrosequencing (patients 1, 3, 5, 7, 10, 11, and
12)werealsopositivebyournovelV6–V8Sutterella-speciﬁcPCR
(Fig. 4A). All four biopsy samples from ileum and cecum, in all
seven Sutterella-positive patients, showed Sutterella products. A
single 260-bp product was observed in positive ampliﬁcations,
and nonspeciﬁc products were never observed. No products were
observed in any Control-GI patients that were evaluated by pyro-
sequencing (patients 16 to 22), the AUT-GI patients that were
negative for Sutterella sequences by V2 pyrosequencing (patients
2, 4, 6, 8, 9, 13, 14, and 15), or water/reagent controls (Fig. 4A).
Furthermore,ourpositivecontrol(DNAfromaculturedS.wads-
worthensis isolate) was positive by PCR. In addition to those pa-
tients evaluated by pyrosequencing, we have assessed ileal and
cecal biopsy samples from eight male AUT-GI children (patients
23a to 30a) and two male Control-GI children (patients 31a and
32a) using our V6–V8 Sutterella PCR. Of these additional sam-
ples,5ofthe8AUT-GIpatientswerepositiveforSutterellainileal
andcecalbiopsysamples(patients24a,25a,27a,28a,and29a).All
biopsy samples from the two additional Control-GI patients were
PCR negative (patients 31a and 32a). In summary, whereas 12 of
23 (52%) AUT-GI children were PCR positive for Sutterella,0o f
the 9 Control-GI children were PCR positive for Sutterella.
In addition, we used the broadly conserved, pan-bacterial
primer 515For in combination with the SuttRev primer in con-
ventional PCR assays (Fig. 4B). These primers amplify a 715-bp
region of the 16S rRNA gene from conserved region 4 to variable
region 8 (C4–V8 assay) (Fig. 3A). Results of the C4–V8 ampliﬁ-
cation were identical to those of the V6–V8 assay. All products
were conﬁrmed to represent Sutterella by sequencing of V6–V8
and C4–V8 products. These results suggest that the SuttRev
primer is sufﬁcient to confer speciﬁcity for Sutterella ampliﬁca-
tion.
Inaddition,wequantiﬁedSutterella16SrRNAgenesequences
in biopsy samples from AUT-GI and Control-GI patients using
real-time PCR (Fig. 3C and D). Real-time PCR analysis using the
SuttFor and SuttRev (V6–V8) primers and a high-coverage Taq-
ManproberevealedsimilarresultstoconventionalPCRassays.By
real-timePCR,Sutterellawasdetectedinpatients1,3,5,7,10,11,
12,24a,25a,27a,28a,and29a(Fig.5),consistentwithbothpyro-
sequencing and conventional PCR results. Sutterella was unde-
tectable in all Control-GI and Sutterella-negative AUT-GI pa-
tients’ samples. Mean Sutterella copy numbers were high in both
the ileum and cecum (in the range of 103 to 105 copies) of
Sutterella-positive patients.
Phylogenetic analysis of Sutterella sequences obtained by
novel PCR assays. Phylogenetic analysis of V6–V8 sequences ob-
tained by library cloning of PCR products revealed similar results
to those obtained by V2 pyrosequencing. While most V6–V8 se-
quences matched most closely with either S. wadsworthensis or S.
stercoricanis, bootstrap values were low at many branches in phy-
logenetictrees(datanotshown).Thus,neithertheV2norV6–V8
regions appear to provide sufﬁcient information for accurate
species-level differentiation.
As C4–V8 PCR assays provide the longest 16S products con-
taining the most variable regions, we also analyzed 480 sequences
(40 sequences per patient, consisting of 20 ileal sequences and 20
cecalsequences)obtainedfromclonelibrariesofC4–V8products
from the 12 Sutterella-positive patients (Fig. 6). No sequences
were obtained from any genus other than Sutterella from any
clonedPCRproducts.Althoughonespeciespredominatedineach
patient, mixed populations of S. wadsworthensis and S. stercori-
canis were detected in several patients. The majority or all of the
C4–V8 sequences from patients 1, 3, 10, 11, 12, 24a, 27a, and 29a
matched most closely with S. stercoricanis, the majority or all of
the C4–V8 sequences obtained from patients 5, 7, and 25a matched
mostcloselywithS.wadsworthensis,andallsequencesobtainedfrom
patient28amatchedmostcloselywithSutterellasp.strainYIT12072.
The predominant Sutterella 16S rRNA gene sequences identiﬁed in
ileal biopsy samples were identical to the predominant Sutterella se-
quencesincecalbiopsysamplesforeachofthepatients.Thus,asingle
predominant sequence was further assessed for each patient.
Alignment of the predominant C4–V8 sequence from each
patientrevealedthatpatients1and24ahadidenticalpredominant
sequences,buttheseweredistinctfromallotherpatients,patients
3,10,11,12,27a,and29ahadidenticalsequences,distinctfromall
other patients, patients 5, 7, and 25a had identical sequences that
TABLE 1 Sequence similarity between 16S rRNA genes (C4–V8 region) of Sutterella from AUT-GI children and other Sutterella isolatesa
Sutterella species
% similarity to rRNA gene from:
Sutterella from patients
S. stercoricanis
(AJ566849)
S. wadsworthensis
(GU585669)
S. parvirubra
(AB300989)
S. sanguinus
(AJ748647)
Sutterella sp.
strain YIT 12072
(AB491210)
1 and
24a
3, 10, 11,
12, 27a,
and 29a
5, 7,
and 25a 28a
Sutterella from patient(s):
1 and 24a 99.9 94.8 93.8 98.5 94.8 95.4 96.3 93.2
3, 10, 11, 12, 27a, and 29a 94.7 93.6 98.4 94.7 95.4 96.4 93.3
5, 7, and 25a 92.8 94.7 100 96.6 93.6 92.9
28a 93.0 92.8 93.6 92.0 95.3
S. stercoricanis (AJ566849) 94.7 94.7 96.6 93.2
S. wadsworthensis (GU585669) 96.6 93.6 92.9
S. parvirubra (AB300989) 95.0 92.6
S. sanguinis (AJ748647) 92.2
Sutterella sp. strain YIT 12072 (AB491210)
a The highest sequence similarities are shown in boldface. Accession numbers are given in parentheses.
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sequence (see Fig. S5 in the supplemental material).
Comparison of percentages of sequence similarity between
these groups (Table 1) revealed 99.9% similarity between se-
quences of patients 1 and 24a and those of patients 3, 10, 11, 12,
27a,and29a.Thisvalueisabovethecutoffvalueof97%similarity,
commonlyappliedforbacterialspeciesdeﬁnition(26),suggesting
that the predominant sequences from these two groups are likely
the same species.
The predominant sequences from patients 1 and 24a and pa-
tients 3, 10, 11, 12, 27a, and 29a had the highest percent similarity
to the S. stercoricanis isolate (98.5% and 98.4% similarity, respec-
tively)andbelow97%similaritycomparedtootherSutterellaiso-
lates (Table 1). In addition, the 16S rRNA gene sequence from
patients 1 and 24a shared 100% similarity with 16S rRNA gene
sequences from uncultured bacteria in GenBank, such as those
derived from intestinal biopsy samples from an ulcerative colitis
patient (i.e., accession no. FJ512128) (27) and mucosal biopsy
samples from the intestinal pouch of a familial adenomatous pol-
yposis patient (i.e., accession no. GQ159316). Similarly, the se-
quences from patients 3, 10, 11, 12, 27a, and 29a shared 100%
similarity with 16S rRNA gene sequences from uncultured bacte-
ria in GenBank, including sequences derived from intestinal bi-
opsy samples from a patient with ulcerative colitis (i.e., accession
no. 512152) (27) and fecal samples from bovines (i.e., accession
no. FJ682648) (28).
Sequences from patients 5, 7, and 25a
had 100% sequence similarity to S. wad-
sworthensisandbelow97%sequencesim-
ilarity to all other Sutterella isolates (Ta-
ble 1). The sequences from patients 5, 7,
and 25a also shared 100% sequence simi-
larityto16SrRNAsequencesinGenBank,
such as those derived from intestinal bi-
opsy samples from an ulcerative colitis
patient(i.e.,accessionno.FJ509042)(27).
The unique sequence found in patient
28a matched most closely with the isolate
Sutterella sp. strain YIT 12072; however,
the similarity was only 95.3% (Table 1).
Thus, based on sequence analysis alone,
Sutterellasequencesfrompatient28acan-
notbeclassiﬁedasSutterellasp.strainYIT
12072 or any of the other known isolates.
The 16S rRNA gene sequence from pa-
tient 28a shared 100% similarity with 16S
rRNA gene sequences from uncultured
bacteria in GenBank that were derived
from intestinal biopsy samples from a
Crohn’s disease patient (i.e., accession no.
FJ503635) (27), human skin popliteal fossa
swab (i.e., accession no. HM305996), and
feces from a 95-year-old woman (i.e.,
accessionno.EF401376)(29).Thus,the16S
rRNA gene sequences from patient 28a
and identical GenBank sequences likely
represent an uncharacterized species of
Sutterella.
Phylogenetic analysis of the predomi-
nant sequences obtained from patient bi-
opsysamplesusingtheC4–V8PCRassayrevealedhighbootstrap
values at most branches and good grouping of members of the
genus Sutterella from other Alcaligenaceae family members and
other Burkholderiales order members (Fig. 7). Thus, sequences
obtained by C4–V8 PCR can be used for accurate species-level
classiﬁcation of Sutterella sequences. This tree demonstrates that
sequencesfrompatients1,24a,3,10,11,12,27a,and29agrouped
most closely with S. stercoricanis (supported by a bootstrap
resampling value of 92%), sequences from patients 5, 7, and 25a
grouped most closely with S. wadsworthensis (supported by a
bootstrap resampling value of 99%), and sequences from patient
28a grouped most closely with the isolate Sutterella sp. strain YIT
12072 (supported by a bootstrap resampling value of 97%) but
formed a distinct phylogenetic lineage.
AUT-GI plasma antibodies bind to S. wadsworthensis pro-
teins. We also sought to determine whether systemic antibody
responses to Sutterella were present in this cohort. The antigens
used for our Western blot analysis were whole-protein lysates
from cultured S. wadsworthensis containing a wide range of pro-
teins,asobservedonCoomassie-stainedSDS-polyacrylamidegels
(datanotshown).Individualpatient’splasmawasassessedforIgG
(Fig. 8A) and IgM (Fig. 8B) antibody immunoreactivity against
the bacterial antigens. Immunoreactive bands were visible for 11
out of 23 (48%) AUT-GI patients. In 10 AUT-GI children, the
immunoreactiveantibodieswereIgG(Fig.8A);onechild(patient
26a) had IgM antibodies (Fig. 8B). In contrast, only 1 of the 9
FIG 7 Phylogenetic tree based on predominant 16S rRNA gene sequences obtained by C4–V8 Sutterella
PCR from AUT-GI patients, Sutterella species isolates, and related species. The tree was constructed by the
neighbor-joining method. Bootstrap values (60%) based on 1,000 replicates are shown next to the
branches.Therewereatotalof653positionsintheﬁnaldataset.Theevolutionarydistanceswerecomputed
usingtheJukes-Cantormethodandareinunitsrepresentingthenumberofbasesubstitutionspersite.The
optimal tree with the sum of branch length of 0.66371685 is shown. The tree is rooted to the outgroup
Escherichia coli. Accession numbers are shown in parentheses. AUT-GI patient sequences are boxed in red.
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tivity to 84-kDa and 41-kDa Sutterella proteins. A total of 11 dis-
tinctimmunoreactiveproteinbandswereidentiﬁed,basedonsize
(104, 89, 84, 62, 56, 50, 48, 44, 41, 30, and 27 kDa). AUT-GI
patients 1 and 5 (both positive by PCR) had the most immunore-
activeproteinbands,withfourproteinbandsincommon(89,62,
56, and 41 kDa). The 89-kDa band was detected by IgG or IgM
antibodies in seven AUT-GI patients. The 56-, 41-, and 30-kDa
bands were detected by IgG antibodies in each of three patients.
The other bands (104, 84, 62, 50, 48, and 44 kDa) were less fre-
quent.
Of the 12 AUT-GI patients that were PCR positive for Sutter-
ella, 8 (66.7%) had plasma IgG antibodies against S. wadsworth-
ensis proteins (patients 1, 3, 5, 7, 10, 11, 24a, and 25a). Three
AUT-GI patients (patients 4, 23a, and 26a) had IgG or IgM anti-
bodiesagainstS.wadsworthensisproteins,butwerePCRnegative.
In total, 15 out of 23 (65.2%) AUT-GI children had evidence of
Sutterella by either PCR or serology (Table 2).
DISCUSSION
WepreviouslyreporteddetectionbypyrosequencingofAlcaligen-
aceae sequences in AUT-GI children (10). More focused analysis
revealedthatthisﬁndingreﬂectsthepresenceofSutterellaspecies.
Whereas 12 of 23 AUT-GI patients (52%) were PCR positive in
bothileumandcecum,0of9Control-GIchildrenwerePCRpos-
itive for Sutterella. Sutterella abundance in the seven Sutterella-
positive AUT-GI patients, assessed by pyrosequencing, ranged
from 1 to 7% of total bacterial sequences. Novel real-time PCR
assays conﬁrmed high copy numbers of Sutterella species in DNA
from ileal and cecal biopsy samples from Sutterella-positive pa-
tients, with averages ranging from 103 to 105 Sutterella 16S rRNA
gene copies ampliﬁed from only 25 ng of total genomic biopsy
DNA.
OTU analysis of V2 region pyrosequencing reads indicated
that only two OTUs accounted for the majority of Sutterella se-
quencesinthesevenAUT-GIpatientsthatwereSutterellapositive
by pyrosequencing. Sequencing of PCR products from V6–V8
and C4–V8 Sutterella-speciﬁc PCR assays corroborated this ﬁnd-
ing.OuranalysisalsosuggeststhatC4–V8Sutterellaproductscan
beaccuratelyclassiﬁedatthespecieslevel.ClassiﬁcationwithRDP
and phylogenetic analysis of Sutterella sequences obtained from
C4–V8 Sutterella-speciﬁc PCR indicated that the predominant
sequencesobtainedfrompatients1,3,10,11,12,24a,27a,and29a
were most closely related to the isolate S. stercoricanis, supported
by a sequence similarity of over 98%. The predominant C4–V8
sequences obtained from patients 5, 7, and 25a were most closely
related to the isolate S. wadsworthensis, supported by a sequence
similarity of 100%. Our results suggest that these two species of
Sutterellaarethedominantphylotypespresentathighlevelsinthe
intestines of AUT-GI children in this cohort. Of the known iso-
lates, the predominant C4–V8 sequence obtained from patient
28a was most closely related to Sutterella sp. strain YIT 12072.
However,thelowsequencesimilarity(95.3%)betweensequences
from patient 28a and Sutterella sp. strain YIT 12072 suggests that
thesearenotlikelytobethesamespecies.Sequencesfrompatient
28a did have 100% sequence similarity to uncultured Sutterella
sequences in GenBank, suggesting that this undeﬁned species has
been detected previously in human samples by nonspeciﬁc tech-
niques.
Sutterella species have been isolated from human and animal
feces (30–32) and have also been isolated from human infections
belowthediaphragm;mostoftenfrompatientswithappendicitis,
peritonitis, or rectal or perirectal abscesses (22, 23). Sutterella se-
quenceshavebeenidentiﬁedinfecalsamplesandintestinalbiopsy
samplesfromindividualswithCrohn’sdiseaseandulcerativecoli-
tis but also from apparently healthy adults (24, 25, 27, 33). Thus,
based on these previous ﬁndings, it remains unclear whether Sut-
terella species contribute to inﬂammation and infection or are
simply normal inhabitants of the human microbiota in some in-
dividuals.Evenifthelatteristhecase,ourresultsdemonstratethat
Sutterella is a major component of the mucoepithelial microbiota
in some children, accounting for up to 7% of all bacteria. Relative
toallotherbacterialgeneraidentiﬁedinbiopsysamples,Sutterella
ranged from the third to eighth most abundant genus in the pa-
tients assessed by pyrosequencing. Only the most abundant Bac-
teroidetes and Firmicutes genera outnumbered Sutterella se-
quences. This result is remarkable given that Sutterella is not
reported as a major component of the microbiota (34).
Loss of commensals in the intestine can affect immune re-
sponses and disrupt colonization resistance to potentially patho-
genic bacteria (17, 19). In our previous study, we found a signiﬁ-
cant loss of commensals, namely, members of the phylum
Bacteroidetes, in AUT-GI biopsy samples (10). Thus, the loss of
Bacteroidetes in AUT-GI children could facilitate the growth of
opportunistic pathogens. Whether Sutterella is pathogenic in
AUT-GI children cannot be determined from current data. How-
ever, the observation that some AUT-GI children have antibodies
that react with S. wadsworthensis proteins is generally consistent
with infection. We detected either IgG or IgM antibodies against
S. wadsworthensis proteins in ~48% (11/23) of AUT-GI children.
FIG 8 Western immunoblot analysis of AUT-GI and Control-GI patients’
plasma antibody immunoreactivity against S. wadsworthensis antigens. (A)
Patients’ plasma IgG antibody immunoreactivity against S. wadsworthensis
antigens. (B) Patients’ IgM antibody immunoreactivity against S. wadsworth-
ensis antigens. 2°, secondary antibody control.
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against S. wadsworthensis proteins. Of the 12 patients that were
positive for Sutterella by PCR, 8 (66.7%) demonstrated plasma
IgG antibodies against S. wadsworthensis proteins. In total, 65.2%
(15 out of 23) of AUT-GI children were either positive by PCR
assaysorhadimmunoglobulinreactivitytoS.wadsworthensispro-
teins. Three AUT-GI patients were negative by PCR but had IgG
or IgM antibodies against S. wadsworthensis proteins. As we only
examined ileal and cecal biopsy samples in this cohort, we cannot
excludethepossibilitythatSutterellaspecieswerepresentinother
regions of the small or large intestine or elsewhere in the body of
these three patients. This could explain the presence of Sutterella-
speciﬁc antibodies without detection of the agent by PCR. Alter-
natively,IgGantibodiesmaypersistlongafterantigenicexposure;
thus,thepresenceofIgGantibodiesmayindicatepastexposurein
somechildren.TheIgMimmunoreactivityofpatient26asuggests
recentorcurrentexposuretoSutterellaantigeninthispatient.Itis
perhaps not surprising that proteins recognized by different pa-
tients’ plasma were variable. It is well recognized that the use of
different strains and species as antigen leads to variations in the
immunoreactive proﬁle of immunogenic proteins (35). Several
Sutterella-positive patients in this study had S. stercoricanis as the
dominant Sutterella species. We recognize this limitation of our
Westernblotanalysis,astheonlyantigenavailabletouswaslysate
from an S. wadsworthensis isolate.
The nature of intestinal damage in autism has not been fully
deﬁned. Abnormalities in intestinal permeability in children with
autism have been reported in two studies (8, 9). In Crohn’s dis-
ease,aconditionassociatedwithincreasedintestinalpermeability,
a generalized enhancement of antimicrobial IgG to many mem-
bers of the intestinal microbiota is reported (36). A defective epi-
thelial barrier could lead to enhanced contact between many
members of the microbiota and antigen-presenting cells in the
lamina propria. If this turns out to be the case in autism, then
antibodies against Sutterella proteins may reﬂect interindividual,
compositional variation in the microbiota, rather than being an
indicationofSutterellainfection.Additionalstudiesarewarranted
in order to draw deﬁnitive conclusions from this immunological
analysis.
In conclusion, we have identiﬁed Sutterella 16S rRNA gene
sequences in mucoepithelial biopsy samples from AUT-GI chil-
dren using nonspeciﬁc, pan-microbial pyrosequencing. We have
further designed and applied novel Sutterella-speciﬁc PCR assays
that conﬁrmed high levels of Sutterella species in over half of
TABLE 2 Summary of results from PCR assays and Western immunoblot analysis
Patient PCR IgG
Molecular mass(es) (kDa)
of bands with IgG IgM
Molecular mass (kDa)
of bands with IgM
Any Ig
positive
Any PCR or
lg positive
AUT-GI
1   89, 62, 56, 41  Yes Yes
2   No No
3 30  Yes Yes
4   89  Yes Yes
5   89, 62, 56, 48, 44, 41  Yes Yes
6   No No
7   50, 44  Yes Yes
8   No No
9   No No
10   30  Yes Yes
11 89, 48  Yes Yes
12   No Yes
13   No No
14   No No
15   No No
23a   104, 30, 27  Yes Yes
24a 89  Yes Yes
25a   89, 56  Yes Yes
26a    89 Yes Yes
27a   No Yes
28a   No Yes
29a   No Yes
30a   No No
Control-GI
16   No No
17   No No
18   No No
19   No No
20   No No
21 84, 41  Yes Yes
22   No No
31a   No No
32a   No No
% positive
AUT-GI 52 43 4 48 65
Control-GI 0 11 0 11 11
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Control-GI children tested in this study. The Sutterella-speciﬁc
molecular assays reported in this study will enable more directed
studies to detect, quantify, and classify this poorly understood
bacterium in biological and environmental samples. With such
speciﬁctechniques,wecanbegintounderstandtheepidemiology
of this bacterium and its associations with human infections and
inﬂammatory diseases, the role Sutterella plays in the microbiota,
and the extent to which Sutterella may contribute to the patho-
genesis of GI disturbances in children with autism.
MATERIALS AND METHODS
Clinical samples. The clinical procedures used for this study population
were previously described (10, 37). For more details, see Text S1 in the
supplemental material. The Institutional Review Board (IRB) at Colum-
bia University Medical Center reviewed and approved the use of deiden-
tiﬁed residual ileal and cecal samples, obtained as described in an earlier
publication (37), and waived the need for patient consent for these anal-
yses, as all samples were analyzed anonymously. All patients underwent
upper and/or lower endoscopic procedures based on clinical imperative.
Pinch biopsy samples were obtained, by an experienced gastroenterolo-
gist, from the terminal ileum (4 per patient) and cecum (4 per patient)
during endoscopy. Endoscopic biopsy samples were immediately placed
in coded tubes, snap-frozen in liquid nitrogen, and stored at 70°C until
processed. All AUT-GI and Control-GI patients and their biopsy samples
evaluated in this study were derived from the initial cohort (37). Patients
assessed by pyrosequencing were restricted to male children between 3
and5yearsofagetocontrolforconfoundingeffectsofgenderandageon
the microbiota (10, 37). This subset comprised 15 AUT-GI (patients 1 to
15) and 7 Control-GI (patients 16 to 22) children. For assessment of
Sutterella sequences in ileal and cecal biopsy samples, we also included 8
additionalmaleAUT-GIchildren(patients23ato30a:6childrenbetween
6 and 7 years of age and 2 children between 8 and 10 years of age) and 2
additional male Control-GI children (patients 31a and 32a: 1 child be-
tween6and7yearsofageand1childbetween8and10yearsofage)from
the initial cohort (37).
Bacterial culture. S. wadsworthensis was obtained from American
Type Culture Collection (ATCC 51579). The isolate was grown in
chopped meat broth in Hungate capped tubes (Anaerobe Systems, Mor-
gan Hill, CA), supplemented with sodium formate and fumaric acid at a
ﬁnal concentration of 0.3% each. Inoculated cultures were incubated at
37°C,andgrowthwasmonitoredat0,6,12,24,and48husingaSutterella-
speciﬁc real-time PCR assay (see below).
DNA extraction. DNA was extracted from individual ileal and cecal
biopsy samples (total of 256 biopsy samples: 128 ileal and 128 cecal, 8
biopsysamplesperpatient[4fromileumand4fromcecum],23AUT-GI
patients and 9 Control-GI patients) and bacterial cultures of S. wads-
worthensisinTRIzol(Invitrogen,Carlsbad,CA)usingstandardprotocols.
DNA concentrations and integrity were determined using a NanoDrop
ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington,
DE) and Bioanalyzer (Agilent Technologies, Foster City, CA) and stored
at –80°C.
Bar-codedpyrosequencingofthebacterialV2regionofthe16SrRNA
gene and analyses are previously described for ileal and cecal biopsy sam-
ples from AUT-GI patients 1 to 15 and Control-GI patients 16 to 22 (10).
The pan-bacterial bar-coded V2 primers, designated V2For and V2Rev,
amplifyaregionofthe16SrRNAgenefromnucleotidepositions27to338
(38)(Fig.3A).Formoredetails,seeTextS1inthesupplementalmaterial.
Sutterella-speciﬁc PCR assay design. Sutterella-speciﬁc 16S rRNA
PCR primers were designed against the 16S rRNA gene sequence for S.
wadsworthensis (accession no. L37785) using Primer Express 1.0 software
(Applied Biosystems, Foster City, CA). Genus speciﬁcity of candidate
primers was evaluated using the RDP (Ribosomal Database Project)
probe match tool. Several potential primer pairs were identiﬁed, but only
one pair showed high speciﬁcity for Sutterella. These primers are desig-
natedhereasSuttFor(nucleotidepositions936to956ofS.wadsworthen-
sis;accessionno.L37785)andSuttRev(nucleotidepositions1177to1195
of S. wadsworthensis; accession no. L37785) (see Table S2 in the supple-
mental material). SuttFor and SuttRev primers amplify a 260-bp region
between variable regions 6, 7, and 8 (V6–V8) of the 16S rRNA gene of
Sutterella (Fig. 3A). For more details on primer and probe speciﬁcity see
Text S1 in the supplemental material.
ConventionalPCRassays.ConventionalPCRfordetectionofSutter-
ella was carried out in 25-l reaction mixtures consisting of 25 ng of
biopsy DNA or 25 pg of genomic DNA from cultured S. wadsworthensis
(ATCC 51579; positive control), 300 nM each of the SuttFor and SuttRev
primers (for V6–V8 ampliﬁcation) or 515For and SuttRev (for C4–V8
ampliﬁcation), 2 l deoxynucleoside triphosphate (dNTP) mix (10 mM;
Applied Biosystems, Foster City, CA), 2.5 lo f1 0  PCR buffer (Qiagen,
Valencia, CA),5Uo fHotStarTaq DNA polymerase (Qiagen), and 5 l
Q-solution (Qiagen). Cycling parameters consisted of an initial denatur-
ationstepat95°Cfor15min,followedby30cyclesof94°Cfor1min,60°C
for 1 min, 72°C for 1 min, and a ﬁnal extension at 72°C for 5 min. The
ampliﬁed product was detected by electrophoresis on a 1.5% agarose gel
stained with ethidium bromide. To conﬁrm speciﬁcity of PCR ampliﬁca-
tion, V6–V8 products were gel extracted and sent for direct sequencing
with SuttFor and SuttRev primers. Additionally, V6–V8 and C4–V8
products were subcloned into the vector pGEM-T Easy (Promega, Mad-
ison, WI), and bacterial libraries were created. One hundred twenty
V6–V8 plasmid clones were sequenced. A total of 480 C4–V8 colonies
were sequenced and analyzed (40 sequences from each of the 12 PCR-
positive patients, 20 sequences each from ileal and cecal biopsy samples).
All V6–V8 and C4–V8 plasmid clones were found to contain Sutterella
sequences, using the RDP classiﬁer tool with a minimum 80% bootstrap
conﬁdenceestimate.TheclosestsequencematchtoSutterellaisolateswas
determined using the RDP seqmatch tool. Sequences from each patient
werealignedusingMacVector,andaconsensussequencewasdetermined
from the predominant Sutterella species in each patient. For details on
Sutterella V6–V8 conventional PCR sensitivity, linearity, and endpoint
detection limit, see Text S1 in the supplemental material.
Quantitative real-time PCR assay. PCR standards for determining
copy numbers of bacterial 16S rRNA genes were prepared from products
ofthepartial16SrRNAgene(V6–V8region)ofS.wadsworthensis(acces-
sion no. GU585669). A representative product with high sequence simi-
laritytotheBacteroidesintestinalis(accessionno.NZ_ABJL02000007)16S
rRNA gene was used with broadly conserved total bacterial primers (10,
39). Products were cloned into the vector pGEM-T Easy (Promega), and
10-foldserialdilutionsoflinearizedplasmidstandardswerecreatedrang-
ing from 5  105 to 5  10° copies. Ampliﬁcation and detection of DNA
by real-time PCR were performed with the ABI StepOne Plus real-time
PCR system (Applied Biosystems). Linearity and sensitivity of plasmid
standards were tested with the SuttFor and SuttRev primers and the
SuttProbe. Ampliﬁcation plots of plasmid standards indicated sensitivity
of detection down to 5 copies of plasmid (Fig. 3C), and standard curves
generated from plasmid dilutions had correlation coefﬁcients of 0.996
(Fig. 3D). For detailed protocols for real-time PCR set up, analysis, and
primers and probe used, see Text S1 in the supplemental material.
Bioinformatics analysis. Operational taxonomic unit (OTU)-based
analysis of pyrosequencing data was carried out in MOTHUR (version
1.8.0) and as previously described (10, 40). For a detailed description of
OTU analysis, see Text S1 in the supplemental material.
Phylogenetic analysis of Sutterella sequences. Phylogenetic analyses
were conducted in MEGA4 (41). Sequence alignments were based on
representativesequencesfromOTU1andOTU2,obtainedfrompyrose-
quencing analysis of the V2 region of the 16S rRNA gene, as well as se-
quences of Sutterella from our V6–V8 (SuttFor and SuttRev ampliﬁca-
tions) conventional PCR assay, and the predominant sequences obtained
from clone libraries of the C4–V8 (515For and SuttRev ampliﬁcations)
conventional PCR assay. Primer sequences were trimmed from the se-
quences. Classiﬁcation was conﬁrmed using the RDP classiﬁer and seq-
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sampleswerealignedwithsequencesfrom8isolatesofSutterellafoundin
the RDP database and sequences from 14 additional related species
(members of the family Alcaligenaceae and order Burkholderiales). Se-
quences from Sutterella isolates and related species were trimmed to the
lengthofthesequencesobtainedfromilealandcecalbiopsysamplesfrom
AUT-GI patients. Phylogenetic trees were constructed according to the
neighbor-joining method with evolutionary distances determined using
the Jukes-Cantor method (42, 43). Trees were rooted to the outgroup
Escherichiacoli(accessionno.X80725).Thestabilityofthegroupingswas
estimated by bootstrap analysis (1,000 replications) using MEGA4. The
percentages of 16S rRNA gene sequence similarity were determined for
Sutterella C4–V8 products and Sutterella isolates using the EzTaxon
server 2.1 (http://www.eztaxon.org/) (44).
Western immunoblots. Soluble proteins of cultured S. wadsworthen-
sis (ATCC 51579) were extracted and used as the antigen in immunoblot
assays. S. wadsworthensis antigens were separated by SDS-PAGE and
transferredtonitrocellulosemembranes.Membraneswereblocked,incu-
bated with each patient’s plasma (diluted 1:100 in blocking solution),
probed with secondary antibodies (either peroxidase-conjugated goat
anti-human IgG [Fc fragment-speciﬁc; Jackson ImmunoResearch, West
Grove, PA] or peroxidase-conjugated goat anti-human IgM [Fc5 frag-
ment-speciﬁc; Jackson ImmunoResearch]), and developed with the ECL
Plus Western blot detection system (Amersham Biosciences, Arlington
Heights, IL). For detailed protocols for antigen preparation and immu-
noblotting see Text S1 in the supplemental material.
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